A phase I/Ib study of lenvatinib and cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) Meeting Abstract
| Authors: | Dunn, L.; Ho, A. L.; Eng, J.; Michel, L. S.; Fetten, J. V.; Warner, E.; Kriplani, A.; Zhi, W. I.; Ng, K. K.; Haque, S.; Pfister, D. G.; Sherman, E. J. |
| Abstract Title: | A phase I/Ib study of lenvatinib and cetuximab in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 365s |
| Language: | English |
| ACCESSION: | WOS:000560368303045 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.6541 |
| Notes: | Meeting Abstract: 6541 -- Source: Wos |
